1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Valbenazine
        1.2.3 Deutetrabenazine
    1.3 Market by Application
        1.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Perspective (2017-2028)
    2.2 Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Region
        2.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Tardive Dyskinesia (TD) Treatment Drugs Market Dynamics
        2.3.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Trends
        2.3.2 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
        2.3.3 Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
        2.3.4 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue
        3.1.1 Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Revenue (2017-2022)
        3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Tardive Dyskinesia (TD) Treatment Drugs Revenue
    3.4 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio
        3.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2021
    3.5 Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Area Served
    3.6 Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service
    3.7 Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Type
    4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2023-2028)
5 Tardive Dyskinesia (TD) Treatment Drugs Breakdown Data by Application
    5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2017-2028)
    6.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
        6.2.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022)
        6.2.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028)
        6.2.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2017-2028)
    6.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
        6.3.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022)
        6.3.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028)
        6.3.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2017-2028)
    6.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        6.4.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022)
        6.4.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2017-2028)
    7.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
        7.2.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2017-2028)
    7.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
        7.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2017-2028)
    7.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        7.4.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
        8.2.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
        8.3.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region
        8.4.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2017-2028)
    9.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
        9.2.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2017-2028)
    9.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
        9.3.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2017-2028)
    9.4 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        9.4.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
        10.2.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
        10.3.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country
        10.4.1 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Neurocrine Biosciences, Inc.
        11.1.1 Neurocrine Biosciences, Inc. Company Details
        11.1.2 Neurocrine Biosciences, Inc. Business Overview
        11.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.1.5 Neurocrine Biosciences, Inc. Recent Developments
    11.2 Teva Pharmaceutical Industries
        11.2.1 Teva Pharmaceutical Industries Company Details
        11.2.2 Teva Pharmaceutical Industries Business Overview
        11.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.2.5 Teva Pharmaceutical Industries Recent Developments
    11.3 Pfizer Inc.
        11.3.1 Pfizer Inc. Company Details
        11.3.2 Pfizer Inc. Business Overview
        11.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.3.5 Pfizer Inc. Recent Developments
    11.4 Biogen
        11.4.1 Biogen Company Details
        11.4.2 Biogen Business Overview
        11.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.4.5 Biogen Recent Developments
    11.5 Novartis AG
        11.5.1 Novartis AG Company Details
        11.5.2 Novartis AG Business Overview
        11.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.5.5 Novartis AG Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 GlaxoSmithKline plc.
        11.7.1 GlaxoSmithKline plc. Company Details
        11.7.2 GlaxoSmithKline plc. Business Overview
        11.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.7.5 GlaxoSmithKline plc. Recent Developments
    11.8 Bayer AG
        11.8.1 Bayer AG Company Details
        11.8.2 Bayer AG Business Overview
        11.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.8.5 Bayer AG Recent Developments
    11.9 Sanofi
        11.9.1 Sanofi Company Details
        11.9.2 Sanofi Business Overview
        11.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction
        11.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
        11.9.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Valbenazine
    Table 3. Key Players of Deutetrabenazine
    Table 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2017-2022)
    Table 8. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region (2023-2028)
    Table 10. Tardive Dyskinesia (TD) Treatment Drugs Market Trends
    Table 11. Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
    Table 12. Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
    Table 13. Tardive Dyskinesia (TD) Treatment Drugs Market Restraints
    Table 14. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Players (2017-2022)
    Table 16. Global Top Tardive Dyskinesia (TD) Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2021)
    Table 17. Ranking of Global Top Tardive Dyskinesia (TD) Treatment Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Tardive Dyskinesia (TD) Treatment Drugs Product Solution and Service
    Table 21. Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Application (2017-2022)
    Table 29. Global Tardive Dyskinesia (TD) Treatment Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Share by Application (2023-2028)
    Table 31. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Neurocrine Biosciences, Inc. Company Details
    Table 62. Neurocrine Biosciences, Inc. Business Overview
    Table 63. Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 64. Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 65. Neurocrine Biosciences, Inc. Recent Developments
    Table 66. Teva Pharmaceutical Industries Company Details
    Table 67. Teva Pharmaceutical Industries Business Overview
    Table 68. Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 69. Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 70. Teva Pharmaceutical Industries Recent Developments
    Table 71. Pfizer Inc. Company Details
    Table 72. Pfizer Inc. Business Overview
    Table 73. Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 74. Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 75. Pfizer Inc. Recent Developments
    Table 76. Biogen Company Details
    Table 77. Biogen Business Overview
    Table 78. Biogen Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 79. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 80. Biogen Recent Developments
    Table 81. Novartis AG Company Details
    Table 82. Novartis AG Business Overview
    Table 83. Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 84. Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 85. Novartis AG Recent Developments
    Table 86. AstraZeneca Company Details
    Table 87. AstraZeneca Business Overview
    Table 88. AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 89. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 90. AstraZeneca Recent Developments
    Table 91. GlaxoSmithKline plc. Company Details
    Table 92. GlaxoSmithKline plc. Business Overview
    Table 93. GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 94. GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 95. GlaxoSmithKline plc. Recent Developments
    Table 96. Bayer AG Company Details
    Table 97. Bayer AG Business Overview
    Table 98. Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 99. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 100. Bayer AG Recent Developments
    Table 101. Sanofi Company Details
    Table 102. Sanofi Business Overview
    Table 103. Sanofi Tardive Dyskinesia (TD) Treatment Drugs Product
    Table 104. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million)
    Table 105. Sanofi Recent Developments
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Valbenazine Features
    Figure 3. Deutetrabenazine Features
    Figure 4. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinic Case Studies
    Figure 7. Others Case Studies
    Figure 8. Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered
    Figure 9. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Tardive Dyskinesia (TD) Treatment Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Region: 2021 VS 2028
    Figure 12. Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Players in 2021
    Figure 13. Global Top Tardive Dyskinesia (TD) Treatment Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment Drugs as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Drugs Revenue in 2021
    Figure 15. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2017-2028)
    Figure 17. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2017-2028)
    Figure 18. North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Country (2017-2028)
    Figure 19. United States Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Country (2017-2028)
    Figure 25. Germany Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Region (2017-2028)
    Figure 35. China Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Country (2017-2028)
    Figure 45. Mexico Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Country (2017-2028)
    Figure 51. Turkey Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 56. Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 57. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 58. Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 59. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 60. GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 61. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 62. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed